Re: A Single Instillation of Epirubicin After Transurethral Resection of Bladder Tumors Prevents Only Small Recurrences. I. Berrum-Svennung, T. Granfors, S. Jahnson, H. Boman and S. Holmang J Urol 2008; 179: 101-106

Journal of Urology

Volumn 180, Issue 5, 2008, Pages 2255-2256

  Oosterlinck, Willem ^a   Sylvester, Richard ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b EORTC DATA CENTER   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; EPIRUBICIN;

BLADDER TUMOR; CANCER GRADING; CANCER RISK; CYSTOSCOPY; FOLLOW UP; HUMAN; LETTER; PRACTICE GUIDELINE; PRIORITY JOURNAL; TRANSURETHRAL RESECTION; TUMOR RECURRENCE;

ADMINISTRATION, INTRAVESICAL; CYSTECTOMY; CYSTOSCOPY; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIRUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE CARE; RISK ASSESSMENT; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 53249121459     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.07.071     Document Type: Letter

References (1)

1. Sylvester R.J., Oosterlinck W., and van derMeijden A. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol 171 (2004) 2186